PRKCE and cancer: Whilst expression changes in PKCε have been described in cancer transcriptomic studies, evidence that any of these effects plays out functionally in cancer patients is missing and this is reflective of a paucity of mechanistic insight into specific PKCε actions for which biomarkers might then inform on its action in disease states.